Cargando…

M214. NALTREXONE INDUCED VISUAL HALLUCINATIONS: A CASE REPORT

Abstract not included.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234373/ http://dx.doi.org/10.1093/schbul/sbaa030.526

Ejemplares similares

M52. VOICES IN THE HEAD: AUDITORY VERBAL HALLUCINATIONS (AVH) IN HEALTHY INDIVIDUALS
por: Goller, Lisa, et al.
Publicado: (2020)

M146. NEUROCHEMICAL MODULATION OF AUDITORY CORTEX FUNCTIONAL CONNECTIVITY IN PATIENTS WITH AUDITORY VERBAL HALLUCINATIONS
por: Weber, Sarah, et al.
Publicado: (2020)

M187. A MULTIMODAL, NEUROIMAGING STUDY OF TDCS MECHANISMS RELATED TO AUDITORY VERBAL HALLUCINATIONS IN HEALTHY INDIVIDUALS
por: Lynn, Marquardt, et al.
Publicado: (2020)

Naltrexone-associated Visual Hallucinations: A Case Report
por: Lee, Dae Bo, et al.
Publicado: (2019)

M200. CLOZAPINE-INDUCED HEPATOTOXICITY: TWO CASE REPORTS
por: Dias, Cintia, et al.
Publicado: (2020)

M75. INCREASED REPULSION OF VISUAL WORKING MEMORY REPRESENTATIONS IN SCHIZOPHRENIA
Publicado: (2020)

M69. IMPROVING VISUAL ATTENTION TO SOCIAL STIMULI IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Klein, Hans, et al.
Publicado: (2020)

M5. A MULTIMODAL STUDY ON THE INFLUENCE OF LEFT-BEHIND CHILDREN’S VISUAL PERCEPTION PROCESSING
por: Wen, Yujie, et al.
Publicado: (2020)

M79. COMPONENTS OF VISUAL SEARCH IN EARLY-ONSET SCHIZOPHRENIA, ADHD AND ASD: AN EYE TRACKING STUDY
por: Canu, Daniela, et al.
Publicado: (2020)

M135. DEVELOPMENT OF VISUAL SCANPATH PATTERN ANALYSIS BASED ON FACIAL EMOTION PERCEPTION ENHANCEMENT TRAINING PROGRAM IN SCHIZOPHRENIA PATIENTS
por: Nam, Beomwoo, et al.
Publicado: (2020)

M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
por: Yoshida, Kazunari, et al.
Publicado: (2020)

M203. ANTIPSYCHOTIC-LIKE EFFECT OF DOXYCYCLINE IN PSYCHOTOMIMETICS SYMPTOMS INDUCED BY AMPHETAMINE
Publicado: (2020)

M161. NEURAL CHANGES INDUCED BY ELECTROCONVULSIVE THERAPY (ECT) IN SCHIZOPHRENIA PATIENTS: A SYSTEMATIC REVIEW
por: Moon, Sun-Young, et al.
Publicado: (2020)

M194. THE USE OF NOVEL PSYCHOACTIVE SUBSTANCES IN THE PRODROMAL PHASE OF SCHIZOPHRENIA- A CASE SERIES
por: Vasiliu, Octavian
Publicado: (2020)

M30. THE ASSOCIATION OF PEER-REPORTED BULLYING AND SOCIAL NETWORK CHARACTERISTICS WITH PSYCHOTIC EXPERIENCES IN CHILDHOOD
por: Steenkamp, Lisa, et al.
Publicado: (2020)

M9. RATS REARED IN SOCIAL ISOLATION INDUCES EPIGENETIC MODIFICATIONS IN THE NMDA RECEPTOR SUBUNITS
por: Loureiro, Camila, et al.
Publicado: (2020)

M207. REVEALING HYPOTHALAMIC PATHWAYS CONTRIBUTION TO OLANZAPINE- INDUCED METABOLIC SYNDROME: FROM MURINE MODEL TO HUMAN TRANSLATION
por: Veneziani, Federica, et al.
Publicado: (2020)

M242. PREDICTORS OF CRIMINAL SENTIMENTS SCALE (CSS-M) SCORES AMONG OUTPATIENTS WITH PSYCHOTIC DISORDERS
por: Zern, Adria, et al.
Publicado: (2020)

M98. IS THERE A DEVELOPMENTAL TRAUMAGENIC PHENOTYPE OF PSYCHOSIS?
por: Bloomfield, Michael, et al.
Publicado: (2020)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

M190. USE OF NULL PRONOUNS IN SCHIZOPHRENIA
por: Chaves, Monica, et al.
Publicado: (2020)

M168. CLINICAL-ANATOMICAL PHENOTYPES OF SCHIZOPHRENIA
por: Kirschner, Matthias, et al.
Publicado: (2020)

M109. WEIGHT GAIN AND THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA
Publicado: (2020)

M133. DISCRIMINATION PHENOMENA AND THE LEVEL OF SCHIZOTYPY
por: Pignon, Baptiste, et al.
Publicado: (2020)

M243. EFFECTIVENESS AND SATISFACTION WITH A SCHIZOPHRENIA RECOVERY DAY PROGRAM
por: Murata, Lisa, et al.
Publicado: (2020)

M110. PREDICTING RISK OF PSYCHOSIS IN A GENERAL POPULATION SAMPLE
por: Kounali, Daphne, et al.
Publicado: (2020)

M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

M64. ADDRESSING THE ROLE OF TIMING ON COGNITION IN SCHIZOPHRENIA
por: Alústiza, Irene, et al.
Publicado: (2020)

M117. ELUCIDATING ARCHITECTURE OF NEGATIVE SYNDROME IN SCHIZOPHRENIA
por: San Ang, Mei, et al.
Publicado: (2020)

M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020)

M198. INVESTIGATIONAL DOPAMINE ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
Publicado: (2020)

M38. PATIENT-PERSPECTIVE: NEED FOR CARE AFTER A FIRST PSYCHOSIS
por: Heijden-Hobus, Inge, et al.
Publicado: (2020)

M24. NETWORK STRUCTURE OF PSYCHOPATHOLOGY SYMPTOMS IN A COMMUNITY SAMPLE OF YOUTH
por: Wang, Emily, et al.
Publicado: (2020)

M231. INTERNALIZED STIGMA AS A PREDICTOR OF EMPLOYMENT STATUS IN PATIENTS WITH SCHIZOPHRENIA
por: Yi Sum, Min, et al.
Publicado: (2020)

M63. TRANSDIAGNOSTIC NEUROCOGNITIVE DEFICITS IN PSYCHIATRY: A REVIEW OF META-ANALYSES
por: East-Richard, Caroline, et al.
Publicado: (2020)

M132. URBANICITY AND PSYCHOSIS IN A CHINESE UNDERGRADUATE POPULATION: PRELIMINARY FINDINGS
por: Coid, Jeremy, et al.
Publicado: (2020)

M180. SUSCEPTIBILITY AND RESILIENCE IN A MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
por: Müller, Flavia, et al.
Publicado: (2020)

M106. VIRTUAL-REALITY COGNITIVE TRAINING AND ASSESSMENT IN SCHIZOPHRENIA
por: Porffy, Lilla, et al.
Publicado: (2020)

M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)

M150. RELATIVES EXPERIENCES OF THE EARLY SIGNS ACTION PLAN
por: Sjöström, Nils, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s0rdutds8no90nafg07dsfrc20